The Wolf Administration recently highlighted the latest accomplishments of the Prescription Drug Monitoring Program (PDMP) and provided an update on prescribing and overdose trends up to October of 2020.

Since the PDMP launched in 2016, there has been a 29.7 percent increase in the prescribing of buprenorphine. In addition, there has been a 58.6 percent reduction in the number of individuals receiving a high dosage of opioid medication, a 52.4 percent reduction in the number of individuals receiving a dangerous drug combination of opioids and benzodiazepines, and a 36.6 percent reduction in opioid prescribing overall.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.